The impact of occlusive vs non-occlusive application of 5-aminolevulinic acid (BF-200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within-patient comparison trial

被引:11
作者
Meierhofer, C. [1 ]
Silic, K. [1 ]
Urban, M. V. [2 ]
Tanew, Adrian [1 ]
Radakovic, Sonja [1 ]
机构
[1] Med Univ Vienna, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Trauma Hosp Klagenfurt, Klagenfurt Am Worthersee, Austria
关键词
5-aminolevulinic acid; actinic keratosis; ALA; BF-200; occlusion; photodynamic therapy; NONMELANOMA SKIN-CANCER; TOPICAL METHYL AMINOLEVULINATE; BASAL-CELL CARCINOMA; PHASE-III; DOUBLE-BLIND; MULTICENTER; EPIDEMIOLOGY; PLACEBO;
D O I
10.1111/phpp.12613
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Photodynamic therapy (PDT) is an effective treatment for actinic keratoses (AK). PDT is usually performed with occlusion of the photosensitizer prior to subsequent illumination. Objectives This study aimed to compare the efficacy and tolerability of occlusive versus non-occlusive application of a 5-aminolevulinic gel (BT-200 ALA) for PDT of multiple AK on the scalp or face. Methods Prospective, investigator-blinded, within-patient comparison study on 45 patients. PDT with occlusion of ALA was performed in a target area on one randomized side of the scalp or face. One week later a contralateral target area received the same treatment except that no occlusion of the ALA gel was performed. 3 and 6 months after PDT, the clearance rate of a predetermined target lesion and the total clearance rate of all AK within the treated areas were determined. PDT-induced pain and skin phototoxicity and cosmetic outcome were also recorded. Results Clearance rate of the target AK and total AK clearance rate at 3 months after PDT was 88.4% and 90.6% for occlusive PDT and 58.1% (P = .001) and 70.4% (P = .04) for non-occlusive PDT. The corresponding values at 6 months after PDT were 69.7% and 72.1% for occlusive PDT and 30.2% (P < .001) and 35.6% (P = .001) for non-occlusive PDT. Pain score and skin phototoxicity were significantly higher after occlusive ALA application. No difference was observed with respect to cosmetic outcome. Conclusions Occlusive application of ALA significantly improves the efficacy of PDT but is associated with more pain and increased phototoxicity.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 15 条
[1]   Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial [J].
Arits, Aimee H. M. M. ;
Mosterd, Klara ;
Essers, Brigitte A. B. ;
Spoorenberg, Eefje ;
Sommer, Anja ;
De Rooij, Michette J. M. ;
van Pelt, Han P. A. ;
Quaedvlieg, Patricia J. F. ;
Krekels, Gertruud A. M. ;
van Neer, Pierre A. F. A. ;
Rijzewijk, Joris J. ;
van Geest, Adrienne J. ;
Steijlen, Peter M. ;
Nelemans, Patty J. ;
Kelleners-Smeets, Nicole W. J. .
LANCET ONCOLOGY, 2013, 14 (07) :647-654
[2]   Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus [J].
Braathen, Lasse R. ;
Szeimies, Rolf-Markus ;
Basset-Seguin, Nicole ;
Bissonnette, Robert ;
Foley, Peter ;
Pariser, David ;
Roelandts, Rik ;
Wennberg, Ann-Marie ;
Morton, Colin A. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) :125-143
[3]   Photodynamic therapy for facial actinic keratosis: A clinical and histological study in Chinese patients [J].
Cai, Hong ;
Wang, Yi-Xia ;
Sun, Ping ;
Yang, Zhi-Yong ;
Tian, Rong ;
Liu, Xiao-Yong ;
Li, Qiang ;
Qiao, Li ;
Liu, Wei .
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2013, 10 (03) :260-265
[4]   Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis [J].
Dirschka, T. ;
Radny, P. ;
Dominicus, R. ;
Mensing, H. ;
Bruening, H. ;
Jenne, L. ;
Karl, L. ;
Sebastian, M. ;
Oster-Schmidt, C. ;
Kloevekorn, W. ;
Reinhold, U. ;
Tanner, M. ;
Groene, D. ;
Deichmann, M. ;
Simon, M. ;
Huebinger, F. ;
Hofbauer, G. ;
Kraehn-Senftleben, G. ;
Borrosch, F. ;
Reich, K. ;
Berking, C. ;
Wolf, P. ;
Lehmann, P. ;
Moers-Carpi, M. ;
Hoenigsmann, H. ;
Wernicke-Panten, K. ;
Hahn, S. ;
Pabst, G. ;
Voss, D. ;
Foguet, M. ;
Schmitz, B. ;
Luebbert, H. ;
Szeimies, R. -M. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (04) :825-836
[5]   Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo [J].
Dirschka, T. ;
Radny, P. ;
Dominicus, R. ;
Mensing, H. ;
Bruening, H. ;
Jenne, L. ;
Karl, L. ;
Sebastian, M. ;
Oster-Schmidt, C. ;
Kloevekorn, W. ;
Reinhold, U. ;
Tanner, M. ;
Groene, D. ;
Deichmann, M. ;
Simon, M. ;
Huebinger, F. ;
Hofbauer, G. ;
Kraehn-Senftleben, G. ;
Borrosch, F. ;
Reich, K. ;
Berking, C. ;
Wolf, P. ;
Lehmann, P. ;
Moers-Carpi, M. ;
Hoenigsmann, H. ;
Wernicke-Panten, K. ;
Helwig, C. ;
Foguet, M. ;
Schmitz, B. ;
Luebbert, H. ;
Szeimies, R. -M. .
BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (01) :137-146
[6]   Solar keratosis: Epidemiology, pathogenesis, presentation and treatment [J].
Holmes, Cara ;
Foley, Peter ;
Freeman, Michael ;
Chong, Alvin H. .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2007, 48 (02) :67-74
[7]  
Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8
[8]   Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model [J].
Maisch, Tim ;
Santarelli, Francesco ;
Schreml, Stephan ;
Babilas, Philipp ;
Szeimies, Rolf-Markus .
EXPERIMENTAL DERMATOLOGY, 2010, 19 (08) :E302-E305
[9]   Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study [J].
Morton, C. ;
Campbell, S. ;
Gupta, G. ;
Keohane, S. ;
Lear, J. ;
Zaki, I. ;
Walton, S. ;
Kerrouche, N. ;
Thomas, G. ;
Soto, P. .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (05) :1029-1036
[10]   A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED® lamp [J].
Reinhold, U. ;
Dirschka, T. ;
Ostendorf, R. ;
Aschoff, R. ;
Berking, C. ;
Philipp-Dormston, W. G. ;
Hahn, S. ;
Lau, K. ;
Jaeger, A. ;
Schmitz, B. ;
Luebbert, H. ;
Szeimies, R. -M. .
BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (04) :696-705